Related Experiment Videos
Novel and emerging therapies for asthma
Thomas M Leath1, Manav Singla, Stephen P Peters
1Department of Medicine, Section on Pulmonary, Critical Care, Allergy & Immunological Diseases, Center for Human Genomics, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Drug Discovery Today
|December 27, 2005
Summary
Novel asthma treatments are emerging, focusing on mediator inhibition, cytokine modulation, and targeting cellular pathways. Recently approved anti-IgE therapy and immune modulation with CpG oligodeoxynucleotides offer new hope for asthma management.
Area of Science:
- Pulmonology
- Immunology
- Pharmacology
Background:
- Asthma treatment has historically focused on established therapies.
- A growing need exists for innovative approaches to manage complex asthma cases.
Purpose of the Study:
- To review current and emerging therapeutic strategies for asthma.
- To highlight advancements in specific and nonspecific mediator inhibition.
- To discuss novel targets including cytokine modulation and cellular pathways.
Main Methods:
- Review of state-of-the-art therapeutic approaches for asthma.
- Analysis of ongoing research in mediator inhibition and cytokine modulation.
- Discussion of targeted therapies for cell recruitment, angiogenesis, and signal/gene transduction.
- Inclusion of recently approved anti-IgE therapy and CpG oligodeoxynucleotides.
Main Results:
- Significant progress has been made in developing targeted asthma therapies.
- Mediator inhibition strategies have evolved over 25 years.
- Cytokine modulation aims to rebalance Th2-Th1 immune responses.
- New therapies target cellular recruitment, angiogenesis, and signal transduction pathways.
Conclusions:
- A diverse range of novel therapeutic options are available for asthma.
- Anti-IgE therapy represents a significant advancement for allergic asthma.
- Immune modulation with CpG oligodeoxynucleotides shows promise.
- Future asthma management will likely involve combination therapies targeting multiple pathways.